MicroRNAs as Regulators of Cisplatin-Resistance in Non-Small Cell Lung Carcinomas

Oncotarget - United States
doi 10.18632/oncotarget.22975
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Plasma microRNAs as Potential Biomarkers for Non-Small-Cell Lung Cancer

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2010English

FEN1 Promotes Tumor Progression and Confers Cisplatin Resistance in Non-Small-Cell Lung Cancer

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2017English

AFAP1‑AS1 Induces Cisplatin Resistance in Non‑small Cell Lung Cancer Through PI3K/AKT Pathway

Oncology Letters
Cancer ResearchOncology
2019English

miRNA‑328 Overexpression Confers Cisplatin Resistance in Non‑small Cell Lung Cancer via Targeting of PTEN

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Vascular Phenotype in Angiogenic and Non-Angiogenic Lung Non-Small Cell Carcinomas

British Journal of Cancer
Cancer ResearchOncology
2002English

Non-Small Cell Lung Cancer-Small Cell Lung Cancer Transformation as Mechanism of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

2020English

Expression of Multidrug Resistance Proteins and Accumulation of Cisplatin in Human Non-Small Cell Lung Cancer Cells

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2005English

Cancer Stem Cells in Lung Cancer: Distinct Differences Between Small Cell and Non-Small Cell Lung Carcinomas

2011English

Cisplatin, Vinblastine, and Bleomycin in Inoperable Non-Small Cell Lung Cancer.

Thorax
PulmonaryRespiratory Medicine
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy